antiPs Cancer Research Results
antiPs, antiPsoriatic: Click to Expand ⟱
| Source: |
| Type: |
| antiPsoriatic
|
Scientific Papers found: Click to Expand⟱
*cognitive↑, *Inflam↓, *AntiBio↑, *Imm↑, *antiOx↑, *Wound Healing↑, *cardioP↑, *SOD↑, *Catalase↑, *GPx↑, *GSTs↑, *MDA↓, *lipid-P↓, *ROS↓, *memory↑, *GABA↑, *antiPs↑, *BioAv↝,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
PSA, |
NA |
|
|
|
BioAv↝, *memory↑, *ROS↓, *AChE↓, *NF-kB↓, *Keap1↝, *NRF2↑, *Inflam↓, *PGC-1α↝, *HO-1↓, *p‑tau↓, *cognitive↑, *BDNF↑, *5HT↑, *Stroke↓, *PARP1↓, *AIF↓, *Casp3↓, NP/CIPN↓, *neuroP↑, *NGF↑, *TNF-α↓, *IL1β↓, *IL18↓, *IL6↓, *VCAM-1↓, *pol-M2 MC↑, *hepatoP↑, *AST↓, *ALAT↓, *LC3II↑, *Beclin-1↑, *p62↑, *COX2↑, *MMP↑, *ATP↑, *GSH↑, *Catalase↑, *GPx↑, *MDA↓, *antiPs↑, *AntiDiabetic↑, *glucose↓, *Insulin↑, *GutMicro↑, *Obesity↓, COX2↓, cycD1/CCND1↓, TumCCA↑, EGFR↓, GSK‐3β↑, Mcl-1↓, *toxicity↓, TumCP↓, Hif1a↓, VEGF↓, ERK↓, LAMs↓, Cyt‑c↑, Casp9↑, Casp3↑, PARP↑, TumCD↑, mitA↑, BACH1↓, P53↓, ROS↑, PD-1↓, NF-kB↓, *Bacteria↓, *AntiViral↑, *mt-ROS?, *PI3K↓, *chemoP↑, ChemoSen↑, eff↑, *toxicity↓, *BioAv↑, *BioAv↑, *eff↑,
*NF-kB↓, PI3K↓, Akt↓, STAT3↓, STAT5↓, IL6↓, COX2↓, iNOS↓, MMPs↓, Src↓, PKA↓, CXCR4↑, VEGF↓, Bcl-2↓, Bcl-xL↓, IAP1↓, Mcl-1↓, survivin↓, cycD1/CCND1↓, HSP90↓, HSP70/HSPA5↓, MAPK↓, HATs↓, HDAC↓, FAK↓, ROS↑, MMP7↓, MMP9↓, α-tubulin↑, cl‑PARP↑, TNF-α↓, BID↑, BAD↑, Cyt‑c↑, Casp3↑, Casp9↑, *AntiArt↑, *antiPs↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Sepsis, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
Dose↝, *Inflam↓, *IL1β↓, *IL6↓, *TNF-α↓, *neuroP↑, *mTOR↓, *IL10↑, *TGF-β↑, *Sepsis↓, *NRF2↑, *antiOx↑, *Catalase↑, *SOD↑, *GPx↑, *ROS↓, *HO-1↑, *PI3K↑, *Akt↑, *hepatoP↑, *MPO↓, *cardioP↑, CDK4↓, CDK6↑, CD47↓, PI3K↓, Akt↓, Hif1a↓, selectivity↑, *MMP↑, *ATP↑, *ER Stress↓, *CHOP/DDIT3↓, *Casp12↓, *GRP78/BiP↓, *p38↓, *p‑JNK↓, *LC3‑Ⅱ/LC3‑Ⅰ↑, *p‑eIF2α↓, *ATF4↓, *XBP-1↓, *Imm↑, *IFN-γ↓, *IL4↓, *GranB/GZMB↓, NK cell↑, radioP↑, *CD4+↑, CD8+↑, *Dose↝, *other↑, *Dose↝, *antiPs↑, *BioAv↝, *GutMicro↑, Dose↝, *IBI↑, TumCP↓, TumCI↓, TumCMig↓, CD8+↑, PGC-1α↑, Akt↓, SCD1↓, *MDA↓, eff↑, *APP↓, *BACE↓, *Aβ↓, *cognitive↑, *neuroP↑, NP/CIPN↓, *Stroke↓, *NLRP3↓, *ALAT↓, *AST↓, *LPS↓, *hepatoP↑, chemoP↑, *creat↓, *Urea↓, *RenoP↑, *eff↑, Apoptosis↑, XIAP↓, IAP2/BIRC3↓, TumVol↓, MALAT1↓, EZH2↓, miR-124-3p↓, eff↑, ChemoSen↑, *compII↑, *compIII↑, *LDL↓, *Obesity↓, QoL↑, PFS↑,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
CD47↓, 1, miR-124-3p↓, 1, PFS↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
PGC-1α↑, 1, XIAP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
SCD1↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 3, Apoptosis↑, 1, BAD↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1, BID↑, 1, Casp3↑, 2, Casp9↑, 2, Cyt‑c↑, 2, IAP1↓, 1, IAP2/BIRC3↓, 1, iNOS↓, 1, MAPK↓, 1, Mcl-1↓, 2, survivin↓, 1, TumCD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
EZH2↓, 1, HATs↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP70/HSPA5↓, 1, HSP90↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↓, 1, PARP↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK4↓, 1, cycD1/CCND1↓, 2, mitA↑, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ERK↓, 1, GSK‐3β↑, 1, HDAC↓, 1, PI3K↓, 2, Src↓, 1, STAT3↓, 1, STAT5↓, 1,
Migration(tgid=13) ⓘ
BACH1↓, 1, FAK↓, 1, LAMs↓, 1, MALAT1↓, 1, MMP7↓, 1, MMP9↓, 1, MMPs↓, 1, PKA↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 2, α-tubulin↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
EGFR↓, 1, Hif1a↓, 2, VEGF↓, 2,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 2, CXCR4↑, 1, IL6↓, 1, NF-kB↓, 1, NK cell↑, 1, PD-1↓, 1, TNF-α↓, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
CDK6↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, ChemoSen↑, 2, Dose↝, 2, eff↑, 3, selectivity↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1, EZH2↓, 1, IL6↓, 1,
Functional Outcomes(tgid=23) ⓘ
chemoP↑, 1, NP/CIPN↓, 2, QoL↑, 1, radioP↑, 1, TumVol↓, 1,
Infection & Microbiome(tgid=24) ⓘ
CD8+↑, 2,
Total Targets: 78
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiArt↑, 1, AntiBio↑, 1, compII↑, 1, Stroke↓, 2,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2, Catalase↑, 3, GPx↑, 3, GSH↑, 1, GSTs↑, 1, HO-1↓, 1, HO-1↑, 1, Keap1↝, 1, lipid-P↓, 1, MDA↓, 3, MPO↓, 1, NRF2↑, 2, ROS↓, 3, mt-ROS?, 1, SOD↑, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
AIF↓, 1, ATP↑, 2, compIII↑, 1, Insulin↑, 1, MMP↑, 2, PGC-1α↝, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 2, glucose↓, 1, LDL↓, 1,
Cell Death(tgid=5) ⓘ
Akt↑, 1, Casp12↓, 1, Casp3↓, 1, GranB/GZMB↓, 1, p‑JNK↓, 1, p38↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↑, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↓, 1, p‑eIF2α↓, 1, ER Stress↓, 1, GRP78/BiP↓, 1, XBP-1↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
Beclin-1↑, 1, LC3‑Ⅱ/LC3‑Ⅰ↑, 1, LC3II↑, 1, p62↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
PARP1↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
mTOR↓, 1, PI3K↓, 1, PI3K↑, 1,
Migration(tgid=13) ⓘ
APP↓, 1, TGF-β↑, 1, VCAM-1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
ATF4↓, 1,
Barriers & Transport(tgid=15) ⓘ
IBI↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CD4+↑, 1, COX2↑, 1, IFN-γ↓, 1, IL10↑, 1, IL18↓, 1, IL1β↓, 2, IL4↓, 1, IL6↓, 2, Imm↑, 2, Inflam↓, 3, LPS↓, 1, pol-M2 MC↑, 1, NF-kB↓, 2, TNF-α↓, 2,
Synaptic & Neurotransmission(tgid=18) ⓘ
5HT↑, 1, AChE↓, 1, BDNF↑, 1, GABA↑, 1, NGF↑, 1, p‑tau↓, 1,
Protein Aggregation(tgid=19) ⓘ
Aβ↓, 1, BACE↓, 1, NLRP3↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 2, BioAv↝, 2, Dose↝, 2, eff↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 2, AST↓, 2, creat↓, 1, GutMicro↑, 2, IL6↓, 2, Urea↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 1, antiPs↑, 4, cardioP↑, 2, chemoP↑, 1, cognitive↑, 3, hepatoP↑, 3, memory↑, 2, neuroP↑, 3, Obesity↓, 2, RenoP↑, 1, toxicity↓, 2, Wound Healing↑, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiViral↑, 1, Bacteria↓, 1, Sepsis↓, 1,
Total Targets: 101
Scientific Paper Hit Count for: antiPs, antiPsoriatic
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1509 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page